Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.neuroimage.2021.117860 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "The antidepressant effect of whole-body hyperthermia is associated with the classical interleukin-6 signaling pathway" [Brain Behav. Immunity 119 (2024) 801-806].
Brain Behav Immun
January 2025
Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA; Vail Health Behavioral Health, Edwards, CO, USA; Department of Spiritual Health, Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA.
Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models" [Translational Oncology volume 39 (2024) 101803].
Transl Oncol
February 2025
Laboratory of Animal Tumor Models, Frontiers Science Center for Disease-Related Molecular Network, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Electronic address:
Corrigendum to "Examination of the effects of kefir on healing factors in a mice burn model infected with E. coli, S. aureus and P. aeruginosa using qRT-PCR" [Burns 49 (2023) 425-431].
Burns
January 2025
Department of Biology, Faculty of Arts and Science, Eskisehir Osmangazi University, Eskisehir, Turkey. Electronic address:
Corrigendum to "Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life" [Eur J Cancer 176 (2022) 88-99].
Eur J Cancer
January 2025
Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany; Side Effect Registry Immuno-Oncology SERIO, Munich, Germany; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!